Concepedia
Statistics
Publications
8
Citations
384
H-Index
Active since
1987
Affiliations
National Institutes of Health(Current)
University College London
National Cancer Institute
Dana-Farber Cancer Institute
Roya Dadmarz is an author at National Institutes of Health specializing in immunology, oncology, and life sciences.
Publications per year
1987–2006
In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2.
Douglas J. Schwartzentruber, Sophia S. Hom, Roya Dadmarz et al. · Journal of Clinical Oncology · 1994 · 159 citations
Medicine, Immunology, Oncology +17
CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion
Roya Dadmarz, Magdalene K. Sgagias, Steven A. Rosenberg et al. · Cancer Immunology Immunotherapy · 1995 · 58 citations · Full text
Life Sciences, Immunology, Oncology +17
Heterogeneity of CLL: high CD23 antigen and αIFN receptor expression are features of favourable disease and of cell activation
Roya Dadmarz, John C. Cawley · British Journal of Haematology · 1988 · 58 citations
Life Sciences, Hematology, Immunology +14
Tumor-infiltrating lymphocytes from human ovarian cancer patients recognize autologous tumor in an MHC class II-restricted fashion.
Roya Dadmarz, A Ordoubadi, Arnold Mixon et al. · PubMed · 2006 · 55 citations
Interleukin-7 selectively enhances natural kill cytotoxicity mediated by the CD56bright natural killer subpopulation.
Roya Dadmarz, David Bockstoce, Sidney H. Golub · PubMed · 1994 · 16 citations
Life Sciences, Cell Biology, Immunology +12
1–5 of 8